Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3, revealing its current stakes in Spire Healthcare Group plc. This disclosure, as per Rule 8.3 of the Takeover Code, indicates that Vanguard holds 14,288,265 ordinary shares, representing 3.55% of the company. The details cover positions and short positions in relevant securities as of July 31, 2026.

The form specifies dealings in 1p ordinary shares, inclusive of minor transactions such as the purchase of 286 shares and sale of 441 shares, both at a price of 2.34 GBP per unit. No additional dealings or derivative transactions were reported, and there are no existing agreements or understandings concerning these securities beyond those disclosed.

No indemnity or other arrangements influencing dealings were mentioned, confirming no further agreements related to voting rights or future acquisitions. The disclosure was made public on August 3, 2026, confirming Vanguard's transparency in its financial operations.